430 related articles for article (PubMed ID: 34432105)
1. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests.
Castelli FA; Rosati G; Moguet C; Fuentes C; Marrugo-Ramírez J; Lefebvre T; Volland H; Merkoçi A; Simon S; Fenaille F; Junot C
Anal Bioanal Chem; 2022 Jan; 414(2):759-789. PubMed ID: 34432105
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
3. Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.
Skov J; Kristiansen K; Jespersen J; Olesen P
Public Health; 2021 Jan; 190():173-175. PubMed ID: 33309006
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics and Personalized Medicine.
Koen N; Du Preez I; Loots du T
Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
[TBL] [Abstract][Full Text] [Related]
5. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.
Di Minno A; Gelzo M; Caterino M; Costanzo M; Ruoppolo M; Castaldo G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563604
[TBL] [Abstract][Full Text] [Related]
6. [Clinical metabolomics : an innovative approach towards preventive and personalized medicine].
Campas M; Schoumacher M; Cirillo A; Le Goff C; De Tullio P; Cavalier É
Rev Med Liege; 2024 Jun; 79(5-6):297-303. PubMed ID: 38869115
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics through the lens of precision cardiovascular medicine.
Lam SM; Wang Y; Li B; Du J; Shui G
J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
9. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
10. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
[TBL] [Abstract][Full Text] [Related]
11. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
12. Metabolomics: moving to the clinic.
Nordström A; Lewensohn R
J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
Ahmed Z
Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.
Eckhart AD; Beebe K; Milburn M
Clin Transl Sci; 2012 Jun; 5(3):285-8. PubMed ID: 22686208
[TBL] [Abstract][Full Text] [Related]
16. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
[TBL] [Abstract][Full Text] [Related]
17. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives.
Letertre MPM; Giraudeau P; de Tullio P
Front Mol Biosci; 2021; 8():698337. PubMed ID: 34616770
[TBL] [Abstract][Full Text] [Related]
19. Cutting-edge strategies and critical advancements in characterization and quantification of metabolites concerning translational metabolomics.
Pillai MS; Paritala ST; Shah RP; Sharma N; Sengupta P
Drug Metab Rev; 2022 Nov; 54(4):401-426. PubMed ID: 36351878
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
